Interferon beta

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

beta-Interferon; IFN β; IFN-β; INF beta; Interferon-beta; Interferon-β; β-Interferon

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Pharmacodynamics (Effect)This section has been translated automatically.

Enhancement of the non-specific humoral defence in viral infections and enhancement of the expression of HLA class I antigens. Promotion of cellular cytotoxicity. Stimulation of CD8 cells.

IndicationThis section has been translated automatically.

Undifferentiated nasopharyngeal carcinoma, viral encephalitis, herpes zoster generalisatus and varicella in immunocompromised patients.

Limited indicationThis section has been translated automatically.

Taking anticoagulant medication during therapy.

Dosage and method of useThis section has been translated automatically.

0,1 million IE/kg KG 3 times/week i.v.

Undesirable effectsThis section has been translated automatically.

InteractionsThis section has been translated automatically.

Like interferon alfa-2a, s. there.

ContraindicationThis section has been translated automatically.

Pregnancy, lactation, children < 14 years, long-term therapy (> 5 weeks).

PreparationsThis section has been translated automatically.

Fiblaferon

Authors

Last updated on: 29.10.2020